Industry News

  • Novo CEO scolds European officials for 'empty promises' on new drugs
    Novo Nordisk  CEO Lars Sørensen says Europe needs to loosen its purse strings to keep drug innovation coming. If austerity-minded…
    in Manufacturers
  • WSJ: Novartis said to eye $16B offer for Actavis
    Actavis has suddenly become the belle of the ball. The Wall Street Journal reports that deal talk is heating up, with…
    in Manufacturers
  • Novartis properly warned of Zometa's risks, jury decides
    Novartis prevailed in the latest court battle over jawbone injuries in Zometa patients. The company did properly warn patients about the…
    in Manufacturers
  • Colitis nod puts J&J's Simponi one step closer to blockbuster
    Johnson & Johnson's new-generation rheumatoid arthritis drug now has a new approval in ulcerative colitis. Simponi, which J&J developed as a…
    in Manufacturers
  • GSK tries novel approach in emerging markets: price cuts
    GlaxoSmithKline CFO Simon Dingemans has found one of the mainstays of retail works just fine for drugs, particularly in emerging markets…
    in Manufacturers
Neupro